DK154208C - Analogifremgangsmaade til fremstilling af p-substituerede 3-fenoxy-1-alkylaminopropanoler eller terapeutisk acceptable salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af p-substituerede 3-fenoxy-1-alkylaminopropanoler eller terapeutisk acceptable salte deraf

Info

Publication number
DK154208C
DK154208C DK239581A DK239581A DK154208C DK 154208 C DK154208 C DK 154208C DK 239581 A DK239581 A DK 239581A DK 239581 A DK239581 A DK 239581A DK 154208 C DK154208 C DK 154208C
Authority
DK
Denmark
Prior art keywords
alkylaminopropanols
phenoxy
analogue
substituted
preparing
Prior art date
Application number
DK239581A
Other languages
Danish (da)
English (en)
Other versions
DK154208B (da
DK239581A (da
Inventor
Enar Ingemar Carlsson
Bill Benjamin Rudol Gustafsson
Bo Torsten Lundgren
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of DK239581A publication Critical patent/DK239581A/da
Publication of DK154208B publication Critical patent/DK154208B/da
Application granted granted Critical
Publication of DK154208C publication Critical patent/DK154208C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK239581A 1980-06-02 1981-06-01 Analogifremgangsmaade til fremstilling af p-substituerede 3-fenoxy-1-alkylaminopropanoler eller terapeutisk acceptable salte deraf DK154208C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8004087A SE8004087L (sv) 1980-06-02 1980-06-02 Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
SE8004087 1980-06-02

Publications (3)

Publication Number Publication Date
DK239581A DK239581A (da) 1981-12-03
DK154208B DK154208B (da) 1988-10-24
DK154208C true DK154208C (da) 1989-03-20

Family

ID=20341101

Family Applications (1)

Application Number Title Priority Date Filing Date
DK239581A DK154208C (da) 1980-06-02 1981-06-01 Analogifremgangsmaade til fremstilling af p-substituerede 3-fenoxy-1-alkylaminopropanoler eller terapeutisk acceptable salte deraf

Country Status (25)

Country Link
EP (1) EP0041491B1 (it)
JP (1) JPS5724335A (it)
KR (1) KR850000869B1 (it)
AT (1) ATE11529T1 (it)
AU (1) AU548290B2 (it)
CS (1) CS241484B2 (it)
DD (1) DD159328A5 (it)
DE (1) DE3168595D1 (it)
DK (1) DK154208C (it)
ES (1) ES502656A0 (it)
FI (1) FI71725C (it)
GR (1) GR74571B (it)
HU (1) HU184860B (it)
IE (1) IE53801B1 (it)
LU (2) LU88317I2 (it)
MY (1) MY8600219A (it)
NL (1) NL930102I2 (it)
NO (1) NO151282C (it)
NZ (1) NZ197237A (it)
PH (1) PH16135A (it)
PL (1) PL135823B1 (it)
PT (1) PT73111B (it)
SE (1) SE8004087L (it)
SU (1) SU1156592A3 (it)
ZA (1) ZA812981B (it)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593119A (en) * 1980-11-28 1986-06-03 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US5334601A (en) * 1984-03-14 1994-08-02 Bodor Nicholas S Soft β-adrenergic blocking agents
US5135926A (en) * 1984-03-14 1992-08-04 Bodor Nicholas S Soft β-adrenergic blocking agents
JPH08799B2 (ja) * 1984-03-14 1996-01-10 ボ−ダ−,ニコラス・エス 緩和β−アドレナリン遮断薬
US4829086A (en) * 1984-03-14 1989-05-09 Bodor Nicholas S Soft β-adrenergic blocking agents
US5202347A (en) * 1984-03-14 1993-04-13 Bodor Nicholas S Soft β-adrenergic blocking agents
AU575153B2 (en) * 1984-04-09 1988-07-21 Du Pont Merck Pharmaceutical Company, The Pharmaceutical compositions and method for treatment for prophylaxis of cardiac disorders
WO1988001614A1 (en) * 1986-09-02 1988-03-10 E.I. Du Pont De Nemours And Company RESOLUTION OF dl-METHYL 3-[4-(2-HYDROXY-3-ISOPROPYLAMINO)PROPOXY]PHENYLPROPIONATE [(dl-ESMOLOL)]
US5274002A (en) * 1987-04-14 1993-12-28 Warner-Lambert Company Trisubstituted phenyl analogs having activity for congestive heart failure
CA2015730C (en) * 1989-05-12 1997-10-07 Sadahiko Iguchi Esters of phenylalkanoic acid
US5232948A (en) * 1990-09-10 1993-08-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
JP6593175B2 (ja) * 2014-01-29 2019-10-23 住友ベークライト株式会社 ブレーキパッドおよびキャリパ装置
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN119060040A (zh) 2019-01-18 2024-12-03 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB673413A (en) * 1950-03-22 1952-06-04 Rhone Poulenc Sa New local anaesthetics which are substituted benzoic esters and processes for making the same
ES361530A1 (es) * 1967-12-18 1970-11-01 Boehringer Sohn Ingelheim Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi 3-sec - alcohilamino propanos racemicos u opticamente activos.
GB1285038A (en) 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
SE354851B (it) * 1970-02-18 1973-03-26 Haessle Ab
FR2132570B1 (it) 1971-04-09 1974-08-02 Lipha
PT66890B (fr) * 1976-08-21 1979-01-25 Hexachimie Procede pour la preparation des aryloxy-1 amino-3 propanol-2

Also Published As

Publication number Publication date
SE8004087L (sv) 1981-12-03
ES8300679A1 (es) 1982-11-01
PL135823B1 (en) 1985-12-31
DK154208B (da) 1988-10-24
NO811799L (no) 1981-12-03
FI71725C (fi) 1987-02-09
AU7116681A (en) 1982-12-02
EP0041491B1 (en) 1985-01-30
PT73111A (en) 1981-07-01
NO151282B (no) 1984-12-03
ZA812981B (en) 1982-05-26
CS241484B2 (en) 1986-03-13
JPS639501B2 (it) 1988-02-29
KR830006177A (ko) 1983-09-20
NL930102I2 (nl) 1994-12-01
FI811671L (fi) 1981-12-03
DK239581A (da) 1981-12-03
HU184860B (en) 1984-10-29
ES502656A0 (es) 1982-11-01
PL231450A1 (en) 1983-03-28
NO151282C (no) 1985-03-13
NZ197237A (en) 1985-01-31
LU88348I2 (fr) 1994-09-09
IE811217L (en) 1981-12-02
JPS5724335A (en) 1982-02-08
AU548290B2 (en) 1985-12-05
EP0041491A1 (en) 1981-12-09
SU1156592A3 (ru) 1985-05-15
GR74571B (it) 1984-06-29
FI71725B (fi) 1986-10-31
MY8600219A (en) 1986-12-31
LU88317I2 (fr) 1994-05-04
PH16135A (en) 1983-07-08
IE53801B1 (en) 1989-03-01
PT73111B (en) 1983-05-11
DD159328A5 (de) 1983-03-02
KR850000869B1 (ko) 1985-06-22
CS404781A2 (en) 1985-06-13
NL930102I1 (nl) 1993-10-01
ATE11529T1 (de) 1985-02-15
DE3168595D1 (en) 1985-03-14

Similar Documents

Publication Publication Date Title
DK154208C (da) Analogifremgangsmaade til fremstilling af p-substituerede 3-fenoxy-1-alkylaminopropanoler eller terapeutisk acceptable salte deraf
DK239481A (da) Fremgangsmaade til fremstilling af 3-fenoxy-1-alkokoxykarbonyl-alkylaminopropanoler
ES8400742A1 (es) Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co.
DK166384C (da) Analogifremgangsmaade til fremstilling af (-)-15-deoxyspergualing og farmaceutisk acceptable syreadditionsssalte heraf samt mellemprodukt
DK598184A (da) 3-aryl-1,2-benzisoxazolsulfonyl- og -sulfinylalkansyrer og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som laegemidler

Legal Events

Date Code Title Description
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1993 00035, 930625

CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1993 00035, 930625

PUP Patent expired